Literature DB >> 6872357

Chemically induced congenital thymic dysgenesis in the rat: a model of the DiGeorge syndrome.

G Oster, K H Kilburn, F P Siegal.   

Abstract

The DiGeorge syndrome, a variable complex of thymic aplasia, congenital heart disease, hypoparathyroidism, and anomalies of the face and neck, is thought to result from exposure to teratogenic agents. A group of congenital defects closely resembling this syndrome can be produced in newborn rats by the administration of the fat-soluble zinc chelating agent WIN 18,446, a bis-dichloroacetylamine. This drug, nontoxic to adult animals, is a powerful teratogen when administered to pregnant rats during days 9-12 of the 21-day gestation period. Our animal data suggest that the human syndrome results from exposure in utero to agents like WIN 18,446, which damage the fetus during a critical period of organogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872357     DOI: 10.1016/0090-1229(83)90196-4

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Errors of morphogenesis and inborn errors of immunity 20 years after the discovery of DiGeorge anomaly.

Authors:  G R Burgio; A G Ugazio
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

2.  The teratogenic effects of a bis(dichloroacetyl)diamine on hamster embryos. Aortic arch anomalies and the pathogenesis of the DiGeorge syndrome.

Authors:  M Binder
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

3.  Congenital heart disease in CHARGE association.

Authors:  R K Wyse; S al-Mahdawi; J Burn; K Blake
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

4.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome.

Authors:  B Morrow; R Goldberg; C Carlson; R Das Gupta; H Sirotkin; J Collins; I Dunham; H O'Donnell; P Scambler; R Shprintzen
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

5.  Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.

Authors:  Brandt C Huddle; Edward Grimley; Cameron D Buchman; Mikhail Chtcherbinine; Bikash Debnath; Pooja Mehta; Kun Yang; Cynthia A Morgan; Siwei Li; Jeremy Felton; Duxin Sun; Geeta Mehta; Nouri Neamati; Ronald J Buckanovich; Thomas D Hurley; Scott D Larsen
Journal:  J Med Chem       Date:  2018-09-28       Impact factor: 7.446

Review 6.  The DiGeorge anomaly.

Authors:  R Hong
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.